Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue

J Hepatol. 2014 Mar;60(3):681. doi: 10.1016/j.jhep.2013.10.030. Epub 2013 Nov 9.

Authors

Andrea Mancuso¹, Chiara Mazzarelli², Giovanni Perricone², Claudio Zavaglia²

Affiliations

¹ Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy. Electronic address: mancandrea@libero.it.
² Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy.

PMID: 24216445
DOI: 10.1016/j.jhep.2013.10.030

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular / therapy*
Female
Humans
Liver Neoplasms / therapy*
Liver Transplantation*
Male
Neoplasm Recurrence, Local / therapy*
Niacinamide / analogs & derivatives*
Phenylurea Compounds / therapeutic use*

Substances

Phenylurea Compounds
Niacinamide